CRL vs DSGN · rev $2.00B vs $214.0M cap
Charles River Laboratories (CRL) versus Design Therapeutics Inc (DSGN) — a side-by-side from cached financials, not a winner call.
Charles River Laboratories (CRL) is a diagnostics & research company listed on US.
Design Therapeutics Inc (DSGN) is a biotechnology company listed on US.
Latest reported CRL revenue for 2026-06-27 was $2.00B. Net income was -$16.3M. CRL currently screens at market cap $7.78B.
Latest reported DSGN revenue for 2026-06-30 was $0. Net income was -$37.8M. DSGN currently screens at market cap $214.0M.
CRL currently screens at market cap $7.78B. DSGN currently screens at market cap $214.0M.
Not investment advice. Open the CRL and DSGN stock pages for the full models.
Not investment advice.